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ABSTRACT: Proteorhodopsin (PR) and Gloeobacter rhodop-
sin (GR) are retinal-based light-driven proton pumps that
absorb visible light (maxima at 520−540 nm). Shifting the
action spectra of these proton pumps beyond 700 nm would
generate new prospects in optogenetics, membrane sensor
technology, and complementation of oxygenic phototrophy. We
therefore investigated the eﬀect of red-shifting analogues of
retinal, combined with red-shifting mutations, on the spectral
properties and pump activity of the resulting pigments. We
investigated a variety of analogues, including many novel ones.
One of the novel analogues we tested, 3-methylamino-16-nor-
1,2,3,4-didehydroretinal (MMAR), produced exciting results.
This analogue red-shifted all of the rhodopsin variants tested, accompanied by a strong broadening of the absorbance band,
tailing out to 850−950 nm. In particular, MMAR showed a strong synergistic eﬀect with the PR-D212N,F234S double mutant,
inducing an astonishing 200 nm red shift in the absorbance maximum. To our knowledge, this is by far the largest red shift
reported for any retinal protein. Very importantly, all MMAR-containing holoproteins are the ﬁrst rhodopsins retaining
signiﬁcant pump activity under near-infrared illumination (730 nm light-emitting diode). Such MMAR-based rhodopsin variants
present very promising opportunities for further synthetic biology modiﬁcation and for a variety of biotechnological and
biophysical applications.
■ INTRODUCTION
Microbial (or type-I) rhodopsins are a family of heptahelical
light-activable membrane proteins found in a broad phyloge-
netic range of microbial life.1 They facilitate various light-driven
functions in their hosts via the active transport of ions (e.g.,
proton, sodium, potassium, or chloride pumps)2 or sensory
signaling mechanisms (e.g., sensory rhodopsins, channelrho-
dopsins).3 The archaeal proton pump bacteriorhodopsin (BR)
was the ﬁrst member of this family to be discovered and has
been well-characterized by various crystallographic and
spectroscopic techniques over the past four decades.4,5
Proteorhodopsins are another archetype of the proton-
pumping rhodopsins that have elicited considerable interest
recently.6 The green-light-absorbing proteorhodopsin (PR)
(λmax = 520 nm) was initially discovered in 2000 in Monterey
Bay during a metagenomic screen of marine uncultured γ-
proteobacteria.7 Many variants of PR have since been found
ubiquitously distributed among various strata of life, including
numerous bacteria, archaea, and eukaryotes.8−11 Gloeobacter
rhodopsin (GR) (λmax = 540 nm) is a far relative of PR that was
discovered in the cyanobacterium Gloeobacter violaceus PCC
7421.12 GR is also a light-driven proton pump and shares ∼30%
sequence identity with PR, while conserving several key
residues involved in its proton pumping function.5
PR and GR contain the typical seven transmembrane α-
helical protein motif (opsin), which binds a molecule of all-
trans retinal (A1) via a covalent Schiﬀ base (SB) linkage with a
buried lysine residue. Upon photoexcitation, retinal isomerizes
from the all-trans to the 13-cis conﬁguration, eliciting speciﬁc
structural changes in the protein. A proton is transferred from
the protonated SB to a nearby Asp (the counterion; D97 in PR,
D121 in GR) and is ultimately released at the extracellular
surface. Another proton is picked up from the cytoplasm to
reprotonate the SB and the retinal undergoes thermal
reisomerization back to the ground state. As a net eﬀect, a
proton is pumped across the cell membrane per photon
absorbed, thereby generating a proton gradient.13
This light-driven proton motive force can be coupled to ATP
synthesis, which is used to drive the growth and survival of PR-
expressing host organisms under energy-limiting condi-
tions.14,15 Both PR and GR also express readily in non-native
hosts such as Escherichia coli,7,16 in contrast to BR.17 PR has
further been shown to be able to contribute to physiological
processes in E. coli such as chemotaxis18 and the heterologous
generation of bioproducts such as biohydrogen.19 These
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features make PR and GR attractive model systems for a variety
of synthetic biology applications. For instance, when expressed
in the cyanobacterium Synechocystis sp. PCC 6803, PR was
observed to stimulate growth upon illumination compared with
a nonfunctional PR mutant.20
A great challenge in many of these applications has been to
extend the action spectrum into the far-red and near-infrared
(NIR) range of the electromagnetic spectrum (≥700 nm),
which is relatively unexplored. It has been suggested that PRs
can complement oxophototrophy further when their spectral
band is shifted bathochromically to utilize photons outside the
range of photosynthetically active radiation (PAR; 400−700
nm),21,22 which is hardly exploited by oxygenic photosyn-
thesis.23,24 Red-light activation is also highly desired in the ﬁeld
of optogenetics, where microbial rhodopsins like channelrho-
dopsins are used to modulate the activity of neurons or other
mammalian cells by light.25,26 Light of wavelength ≥700 nm
penetrates much further into biological tissue, which for
instance would be very useful for the optogenetic stimulation
of deeper brain regions.
One of the primary approaches to shift the action spectrum
of microbial rhodopsins has been to modify the protein (opsin)
environment. Several red-shifted mutants of PR and GR have
been constructed using random mutagenesis screens27 or
targeted mutagenesis of speciﬁc binding pocket residues.28
However, most mutants are strongly functionally impaired,
which presents a major drawback. Nonetheless, a few red-
shifted mutants have been identiﬁed that retain 30−50% of the
pumping activity of the wild-type protein, such as the single
mutant PR-T101A (PR-TA) (λmax = 536 nm) and the double
mutant PR-D212N,F234S (PR-DNFS) (λmax = 540 nm).
27,29
Chromophore substitution is another veriﬁed strategy to shift
the absorption spectrum of these proteins. We have previously
demonstrated red and blue shifts in the absorbance bands of
PR, GR, and PR-DNFS using analogues of A1 with diﬀerent
ring modiﬁcations.29 Of these, the analogue all-trans-3,4-
dehydroretinal (A2) induced a signiﬁcant red shift (26−32
nm) in all pigments while largely retaining the pump activity.29
A2 is the only other naturally occurring retinal, and it has been
found in the photoreceptor cells of certain ﬁsh, invertebrates,
and amphibians.30−32 It was also shown to cause a red shift in
the absorbance bands of archaeal rhodopsins with a minimal
eﬀect on activity.33,34 The additional conjugation in A2 between
C3 and C4 (Figure 1b) decreases the energy gap for the π−π*
transition, causing the spectral shift to longer wavelengths
(Tables 1 and S1 and Figure S1).
In this report, we speciﬁcally focus on red-shifting retinal
analogues. We elaborated the conjugation of A2 by adding
diﬀerent electron-withdrawing substituents at C3 in the β-
ionone ring and/or at C13 or C14 in the polyene chain.
Analogues modiﬁed at C13 or C14, however, showed poor
reactivity or low stability of the resulting holoprotein
(Ganapathy and de Grip, unpublished). Here we report on
the ring-modiﬁed analogues all-trans-3-methoxy-3,4-dehydror-
etinal (MOA2), all-trans-3-dimethylamino-16-nor-1,2,3,4-dide-
hydroretinal (DMAR), and all-trans-3-methylamino-16-nor-
1,2,3,4-didehydroretinal (MMAR) (Figure 1). Promising
analogues were combined with red-shifted mutants (Figure
2). While all of the analogues tested yielded red-shifted
pigments, MMAR was ﬁnally identiﬁed as the most promising
analogue from our study, inducing bathochromic shifts of up to
an astonishing 200 nm while retaining activity in NIR light.
MMAR pigments have broad potential for a variety of
biotechnological, optogenetic, and oxyphototrophic applica-
tions.
■ RESULTS AND DISCUSSION
Characterization of the Proton Pumps. In view of the
red-shifting potential of the F234S mutation in PR,27 we
engineered the equivalent mutation in GR (F260S; Figure 2).
In contrast to PR, the mutant GR-F260S (GR-FS) showed only
a 9 nm red shift, but also, in contrast to PR, high expression
levels (ca. 105 molecules/cell) and pump activity (Table 1)
were observed. The mutants PR-DNFS, PR-TA, and GR-FS
(Figure 2) were constructed using mismatch PCR, as described
in the Supporting Information (SI). PR, GR, and their mutants
were recombinantly expressed in E. coli strain UT5600 under
control of the lac promoter. Opsin expression was induced by
addition of IPTG to the cell culture. All of the opsins could be
fully regenerated with A1 and A2 upon addition of retinal either
to the culture or to isolated membrane vesicles.29 Good
regeneration rates were also observed with MOA2 and MMAR,
but complete regeneration with DMAR was diﬃcult to achieve.
The presence of a C-terminal His6 tag allowed extensive
puriﬁcation of the pigments after solubilization with the
detergent n-dodecyl-β-D-maltoside (DDM). The absorbance
maxima of pigments that were not very stable in DDM were
estimated by measuring the pigment absorbance in intact
Figure 1. Chemical structures of retinal analogues used in this study:
[a] A1; [b] A2; [c] MOA2; [d] DMAR; [e] MMAR. For spectral
properties, see Figure S1 and Table S1.
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membrane vesicles (see Selected Materials and Methods). To
test their proton pumping activity under red and near-infrared
illumination, the pigments were assayed in intact starved cells
under white light (800 μE·m−2·s−1), 617 nm light-emitting
diode (LED) (1500 μE·m−2·s−1), 660 nm LED (800 μE·m−2·
s−1), and 730 nm LED (150 μE·m−2·s−1) illumination.
In all of the pigment variants tested in the current study, A1
and A2 corroborated the results reported before with PR, GR,
and PR-DNFS (Table 1). A2 caused a 22−32 nm red shift in
the absorbance bands and retained strong proton pumping
activity upon white light illumination (50−100% of A1), except
for PR-DNFS (23%). However, under 730 nm illumination,
very low but measurable activity was observed only for the A2
pigments of GR and GR-FS (Figures 5e and 6e and Table 1).
This was expected, considering the width of the emission band
of the 730 nm LED and the absorbance bands of the pigments.
While searching for further red-shifting analogues, we
noticed two A2 derivatives with electronegative groups at C3:
3-methoxy-A2 (MOA2), which red-shifts visual rhodopsins up
to 130 nm with retention of activity,35 and a 3-dimethylami-
nophenyl derivative, which red-shifted channelrhodopsin2 by
40 nm but slowed down the photocycle.36
Properties of MOA2 and DMAR Pigments. We ﬁrst
tested all-trans MOA2 (Figure 1c), which contains the strong
electron-withdrawing methoxy group at C3 on the β-ionone
ring. The π system is extensively delocalized over the lone
electron pairs on the oxygen atom of MOA2, resulting in a large
red shift of ca. 50 nm relative to A1 (λmax = 434 nm for MOA2
in DMF) along with a broadening of the main absorbance band
(Table S1 and Figure S1). All of the opsin variants tested
reacted smoothly with this analogue. The resulting pigments
were quite stable in DDM, allowing extensive puriﬁcation.
MOA2 not only induced very large red shifts in λmax (55−90
nm, depending on the opsin) but also increased the half-width
of the spectra. As a result, all the spectra tail out clearly beyond
700 nm up to 800−850 nm (Figures 3a, 4a, 5a, and 6a).
Under white light illumination, all of the MOA2 pigments
tested showed moderate proton pump activity (20−40% of that
for the corresponding A1 pigments). We expected this ratio to
increase in red light in view of the red-shifted absorbance bands
of the MOA2 pigments. However, hardly any pump activity
could be detected with 617 nm LED illumination (Table 1 and
Figures 3, 5, and 6), despite the high photon ﬂux of the LED
source used and its spectral overlap with the central part of the
absorbance band of the pigments.
The strong electronegative character of the methoxy
substituent apparently aﬀects the photocycle to such an extent
that lower-energy excitation >600 nm cannot drive it to
completion, thus eﬀectively suppressing the pump mechanism.
We are in the process of investigating this perplexing
phenomenon in a follow-up study using femtosecond spec-
troscopy and a computational investigation of the energetic
constraints involved in photoisomerization of MOA2 pigments.
Subsequently, we turned to the dimethylaminophenyl
derivative. The analogue tested by AzimiHashemi et al.36 has
an aromatized ring moiety with a dimethylamino substituent at
C3 but lacking methyl groups. We have previously reported
that the aromatic phenylretinal, which also lacks methyl groups
on the β-ionone ring, did not form a stable pigment with GR.29
Therefore, we decided to position additional methyl groups at
C1 and C5 of the dimethylaminophenyl moiety to improve the
ﬁt and stability of the retinal analogue inside the binding
pocket.37,38 This resulted in a novel derivative, all-trans-3-
dimethylamino-16-nor-1,2,3,4-didehydroretinal (DMAR) (Fig-
ure 1d). DMAR, however, showed low reactivity with most
opsins and very low stability of the resulting pigments in DDM.
Table 1. Absorbance Maximum (λmax) Values and Proton
Pumping Scores of the Analogue Pigments Generated in
This Study
H+ c
opsin
retinal
analogue
λmax
(nm)a white 617 nm 660 nm 730 nm
A1 520 +++ + − −
PR A2 552 +++ +++ + −
MOA2 585 ++ − nd nd
DMAR 558 − + nd nd
MMAR 567 − + + ++
A1 540 ++ nd − −
PR-DNFS A2 566 + nd − +
MMAR ∼740 − nd − ++
A1 536 + nd + −
PR-TA A2 563 + nd + +
MMAR 561b − nd + ++
A1 540 ++++ +++ ++ −
A2 566 ++++ ++++ ++++ +
GR MOA2 620 ++ − nd nd
DMAR 538b + + nd nd
MMAR 570 + + ++ ++
A1 549 ++++ ++++ +++ −
A2 571 +++ nd ++++ ++
GR-FS MOA2 630 ++ − − −
MMAR 571b + + ++ ++++
aλmax of puriﬁed protein.
bλmax from hydroxylamine diﬀerence
spectrum in vesicles. cProton pumping activity normalized within
each light condition to the highest pumping rate measured under that
condition: ++++, 100−70%; +++, 70−40%; ++, 40−20%; +, 20−5%;
−, <5% (see Selected Materials and Methods for relative rates between
sets and further explanation). nd = not determined.
Figure 2. [a] Homology model of PR selectively displaying in cyan the
mutation sites F234 and T101 near the retinal binding pockets and
D212 in the loop region. [b] Homology model for GR selectively
displaying in cyan the mutation site F260 in the retinal binding pocket.
Retinal is represented in cyan as a space-ﬁlling residue.
Journal of the American Chemical Society Article
DOI: 10.1021/jacs.6b11366
J. Am. Chem. Soc. 2017, 139, 2338−2344
2340
Of all the pigments tested, only PR:DMAR could be
successfully puriﬁed (Figure 3a), and it showed a broad red-
shifted absorbance band peaking at 558 nm (38 nm red shift
relative to A1) and tailing out to at least 850 nm. On the
positive side, while the tested DMAR pigments showed
relatively low pumping rates under white light illumination
(<10% of that for A1; Table 1), this activity persisted with 617
nm illumination (Figures 3b and 5c).
We surmised that the bulky dimethylamino group might
sterically hinder the ﬁt and reactivity of DMAR in the retinal
binding pocket. Hence, we anticipated that the reactivity of this
analogue and the stability of the resulting pigments would
improve if the dimethylamino group in DMAR were replaced
by a monomethylamino group. This group is not much bulkier
than the methoxy group in MOA2, an analogue that yields very
stable pigments. This strategy resulted in MMAR (Figure 1e).
Properties of MMAR Pigments. MMAR yielded impres-
sive results. This analogue contains only a single methyl group
on the C3 amino substituent, which does not appear to aﬀect
the absorbance of the compound in DMF, as DMAR and
MMAR display similar complex absorbance bands with λmax ≈
434 nm and an electronic sideband at 360 nm (Figure S1).
MMAR indeed was rapidly incorporated into all of the
opsins, and the resulting pigments showed a clear increase in
stability and proton pumping activity compared with DMAR.
MMAR thus came out as the most promising analogue
identiﬁed from our study.
MMAR induced bathochromic shifts in all of the opsins
tested: a 47 nm red shift in the λmax of PR and a 23−30 nm red
shift in the λmax of PR-TA, GR, and GR-FS (Table 1),
accompanied by extensive spectral broadening and tailing up to
850−950 nm (Figures 3a, 4a, 5a, and 6b). Spectacular, however,
was the ca. 200 nm red shift (equivalent to 5005 cm−1) relative
to A1 in PR-DNFS, which will be discussed in more detail
below. Except for GR-FS:MMAR, the obtained MMAR
pigments were suﬃciently stable in DDM to allow puriﬁcation.
All of the pigments were also spectrally assayed in the
membrane-bound state (plasma membrane vesicles isolated
from the E. coli cells) using an end-on spectrophotometer (see
Selected Materials and Methods and the SI). The latter data
were very similar to those obtained with the puriﬁed pigments,
conﬁrming that detergent solubilization does not measurably
aﬀect the spectral properties.
Upon protonation of the counterion (D97; pKa ∼ 6.5), PR-
derived pigments exhibited a 20−30 nm red shift in the main
absorbance band (Figure S2a). Among all of the PR pigments,
only PR:MMAR displayed a complex absorbance band with
λmax at 567 nm containing a 770 nm composite band, which
tails oﬀ to 850 nm (Figure 3a). Surprisingly, the entire band
shape of this pigment was very sensitive to protonation
(presumably of the counterion D97), since acidiﬁcation led to a
strong enhancement of the lower-energy bands (Figure S2b).
While MMAR does not appear to have a signiﬁcant eﬀect on
the pKa of the counterion, the charge distribution and
electrostatic interactions in the retinal binding pocket
apparently have a strong inﬂuence on its spectral properties.
The inﬂuence of the binding pocket environment was further
obvious in the PR-TA mutant, where MMAR also induced a
red shift (25 nm), but a much smaller one than in PR (47 nm),
as well as a broad absorbance band tailing out to 850 nm but
without the wings observed in PR:MMAR (not shown).
We surmise that the exceptional spectral broadening seen in
the MMAR pigments may originate from a population of
degenerate electronic or vibronic transitions, the absorbance
cross-section of which apparently strongly depends on the local
charge distribution. This is most strikingly seen in PR-DNFS,
where binding of MMAR induced a very large red shift of about
200 nm, creating a complex absorbance band with a broad
maximum around 740 nm (Figure 4a). The band shape here is
in fact a mirror image of the one for PR:MMAR, since now the
lower-energy transitions contribute most strongly to the
absorbance band (Figures 3a and 4a). The band shape of PR-
DNFS:MMAR also shows some pH dependence, with the
Figure 3. Analogue pigments of PR. [a] Normalized absorbance
spectra of puriﬁed pigments in DDM containing A1 (black), A2
(pink), MOA2 (green), DMAR (orange), or MMAR (blue). [b−d]
Proton pumping activities of the pigments (same colors as in [a]) in
starved E. coli UT5600 cells upon illumination with [b] 617 nm, [c]
660 nm, and [d] 730 nm LEDs. Controls without retinal are
represented as dotted gray lines.
Figure 4. Analogue pigments of PR-D212N,F234S. [a] Normalized
absorbance spectra of puriﬁed pigments in DDM containing A1
(black), A2 (pink), MOA2 (green), or MMAR (blue). [b−d] Proton
pumping activities of the pigments (same colors as in [a]) in starved E.
coli UT5600 cells upon illumination with [b] white light, [c] a 660 nm
LED, and [d] a 730 nm LED. Controls are the same as in Figure 3.
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hypsochromic shoulder presenting a congruent red shift upon
acidiﬁcation and the 740 band somewhat increasing (not
shown). Apparently, the mutation strongly facilitated the
change in band shape, and this can still be further enhanced
by acidiﬁcation. To our knowledge, this is the ﬁrst report of
such a large synergistic spectral shift induced by a retinal
analogue in an opsin mutant.
The extremely large red shift in PR-DNFS:MMAR in
combination with the broad trilobal absorbance band is
impressive and unexplained as of yet. However, it is clear that
the electronic transitions involved in shaping the PR:MMAR
absorbance band are particularly sensitive to the local charge
distribution. This is obvious upon counterion protonation as
well as in the F234S mutant, both sites situated in or near the
binding pocket (Figures 2 and S3). This eﬀect is then expected
to be protein-dependent, and in fact the equivalent GR mutant
GR-FS:MMAR displays only a moderate 23 nm red shift in λmax
with just a long spectral tail extending to 950 nm (Figure 6b). A
major diﬀerence in the binding site between PR and GR is the
presence of a large aromatic Phe residue (F152) near the retinal
ring in PR, where GR has only a small Gly hydrogen (G178) in
the equivalent position (Figure S3). The Phe ring may ﬁxate
and/or interact with the aromatic ring of MMAR in such a way
as to select or enhance low-energy electronic transitions.
All of the MMAR pigments displayed relatively low proton
pumping activities under white light, in the range of 0.1−1.5
H+·s−1 per protein (5−10% of the rate displayed with A1 and
A2). Most importantly, however, we observed that the proton
pumping activity persisted at about the same level with red light
illumination. Signiﬁcant activity was retained with 730 nm LED
illumination, in fact strongly surpassing that of any remaining
A2 activity (Figures 3d, 4d, 5e, and 6e and Table 1). Because of
the low intensity of the 730 nm LED, an absolute comparison
cannot yet be made. However, we estimate that under equal-
intensity illumination, the pumping activity with the 730 nm
LED would be at least as high as that under white light. Even
the PR-DNFS mutant, which is quite impaired in its pump
function (30−40% of that for the wild type in white light with
A127,29) clearly displays pumping activity under 730 nm LED
illumination with MMAR (Figure 4d). The highest activity
under this NIR light was observed for the GR-FS:MMAR
combination (0.2 H+·s−1 per protein; Figure 6e). However, this
rate will increase considerably with higher light intensity and a
broader frequency range.
The inﬂuence of the local charge environment on its
absorbance band thus renders MMAR an excellent candidate
for the spectral modulation of microbial rhodopsins. Consid-
ering the pumping activity of GR-FS:MMAR and the unique
spectral properties of PR-DNFS:MMAR, these analogue
pigments would make very promising starting materials for
further engineering strategies. For instance, the PR-
DNFS:MMAR combination may be a good starting point for
Figure 5. Analogue pigments of GR. [a] Normalized absorbance
spectra of His-tag-puriﬁed pigments in DDM containing A1 (black),
A2 (pink), MOA2 (green). or MMAR (blue). [b] Hydroxylamine
diﬀerence spectrum of the DMAR pigment (orange) in membrane
vesicles. [c−e] Proton pumping activities of the pigments (same colors
as in [a]) in starved E. coli UT5600 cells upon illumination with [c]
617 nm, [d] 660 nm, and [e] 730 nm LEDs. Controls are the same as
in Figure 3.
Figure 6. Analogue pigments of GR-F260S. [a] Normalized
absorbance spectra of His-tag-puriﬁed pigments in DDM containing
A1 (black), A2 (pink), and MOA2 (green). [b] Hydroxylamine
diﬀerence spectrum of the MMAR pigment (blue) in membrane
vesicles. [c−e] Proton pumping activities of the pigments (same colors
as in [a]) in starved E. coli UT5600 cells upon illumination with [c]
white light, [d] a 660 nm LED, and [e] a 730 nm LED, Controls are
the same as in Figure 3.
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directed evolution and computational studies so as to improve
the pump function and/or to further red-shift the absorbance
band.
Next to the proton pump function, the MMAR pigments
could have an interesting alternative function as voltage sensors.
The D97N mutant of PR:A1 was shown to be a sensitive sensor
of the membrane voltage, exhibiting strongly voltage-dependent
ﬂuorescence emission that peaks around 700 nm.39 In
preliminary experiments, we observed very strong red-shifted
ﬂuorescence of PR-D97N:MMAR peaking around 800 nm (not
shown). This spectral range would be quite useful for
biotechnological and optogenetic applications, and we are
currently further exploring this prospect.
For microbial, cellular, or in vitro applications, the opsins can
be easily expressed in transformed cells and the retinal
analogues applied to the culture or to membrane vesicles. For
in vivo applications, the opsins can be expressed in situ (e.g., via
recombinant virus) and the retinal locally applied by stereo-
tactic injection.
■ CONCLUSION
We have utilized a novel very eﬀective retinal analogue in
combination with site-directed mutagenesis to generate novel
rhodopsin proton pump variants that for the ﬁrst time can be
activated by near-infrared light. This research has important
implications for synthetic biology strategies to complement
oxygenic photosynthesis20 and toward (near-infra-)red light
activation of biotechnological and optogenetic tools and
membrane sensors.25,26,39,40
■ SELECTED MATERIALS AND METHODS
Most of the materials and methods used in this study are detailed in
the Supporting Information. Here we elaborate upon the methods that
are most relevant to the data presented above.
Diﬀerence Spectroscopy upon Bleaching with Hydroxyl-
amine. The main absorbance bands of the pigments in membrane
vesicles isolated from E. coli cells or in a solubilized state were
extracted by reaction with hydroxylamine (see the SI). Hydroxylamine
speciﬁcally attacks the Schiﬀ base bond between lysine and retinal.
This results in a loss of the main pigment absorbance band, thereby
generating a new absorbance band of the liberated retinaloxime
(peaking in 1% DDM between 350 and 402 nm; cf. Table S1).
Subtracting the spectrum taken before from that taken after incubation
with hydroxylamine generates a diﬀerence spectrum that resolves a
negative band corresponding to the loss of the proteorhodopsin
absorbance band. This reaction thus eliminates the contributions from
other membrane components (cytochromes, excess retinal), allowing
for a more accurate estimate of the absorbance maximum. This
protocol could also be applied to membrane vesicles, which is
necessary to extract the absorbance bands of pigments that were not
suﬃciently stable in DDM or did not survive the puriﬁcation process.
Furthermore, the generated retinal oxime could be used to determine
the molar absorbance values of the various analogue pigments (details
provided in the SI). This aided in the determination of functional
expression levels, which were required to calculate molecular pumping
rates for all pigments (details provided in the SI).
Normalization of Proton Pumping Activity. The proton
pumping activities of the pigments were measured using four diﬀerent
illumination conditions, namely, white light (DLED9-T; range 400−
850 nm), 617 nm LED (600−640 nm), 660 nm LED (620−680 nm),
and 730 nm LED (690−760 nm). We used intact E. coli cells, which
maintain uniform orientation of the proton pumps in the membrane.
The cells were starved for an optimum duration of 4 days in a minimal
buﬀer and further incubated in the presence of the K+ ionophore
valinomycin. Under these conditions, proton pumping rates could be
extracted as described previously.29 These probably do not yet reﬂect
the maximally attainable rates, since the applied light intensities are
still limiting. Hence, because of the variation in the photon ﬂux of the
illumination sources used (see the main text), the pumping rates
within a set of light conditions were normalized to the highest
pumping activity obtained in that set (Table 1). For instance, GR-
FS:A1 has the highest pumping rate with white light (9.4 H+·s−1 per
protein); hence, the white light pumping rates for all of the pigments
were normalized to 9.4. For comparison among the diﬀerent light
regimes, we can further normalize the highest pumping rates obtained
in each light regime to the highest pumping rate under white light
illumination. For reference, these values are white light (GR-FS:A1,
100%), 617 nm (GR-FS:A1, 80% of white light), 660 nm (GR:A2,
15% of white light), and 730 nm (GR-FS:MMAR, 2% of white light).
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